BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22049975)

  • 1. Interdisciplinary approach towards female patients with Fabry disease.
    Weidemann F; Niemann M; Sommer C; Beer M; Breunig F; Wanner C
    Eur J Clin Invest; 2012 Apr; 42(4):455-62. PubMed ID: 22049975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
    Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
    Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fabry disease].
    Jakubowska E; Ryba M; Hruby Z
    Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological complications of Fabry-disease].
    Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
    Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fabry cardiomyopathy: models for the cardiologist.
    Weidemann F; Niemann M; Warnock DG; Ertl G; Wanner C
    Annu Rev Med; 2011; 62():59-67. PubMed ID: 21090963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge].
    Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Baron R; Breunig F; Schaefer R; Strotmann J; Wanner C
    Med Klin (Munich); 2009 Jan; 104(1):10-9. PubMed ID: 19142592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical and pathological studies on a carrier of Fabry's disease manifesting bouts of pain in the extremities].
    Katayama M; Kobayashi T; Ohnishi A; Goto I; Kuroiwa Y
    Rinsho Shinkeigaku; 1984 Jun; 24(6):575-80. PubMed ID: 6094070
    [No Abstract]   [Full Text] [Related]  

  • 8. Fabry disease.
    Tarabuso AL
    Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge].
    Weidemann F; Niemann M; Sommer C; Beer M; Breunig F; Wanner C
    Med Klin (Munich); 2010 Sep; 105(9):627-34. PubMed ID: 20878300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
    Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
    J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hearing status in 12 female and 15 male Japanese Fabry patients.
    Sakurai Y; Kojima H; Shiwa M; Ohashi T; Eto Y; Moriyama H
    Auris Nasus Larynx; 2009 Dec; 36(6):627-32. PubMed ID: 19261412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
    Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
    Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and treatment of renal involvement in Fabry disease.
    Branton M; Schiffmann R; Kopp JB
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease.
    Yokoi T; Kobayashi H; Shimada Y; Eto Y; Ishige N; Kitagawa T; Otsu M; Nakauchi H; Ida H; Ohashi T
    J Gene Med; 2011 May; 13(5):262-8. PubMed ID: 21520359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fabry disease--diagnostic guideline].
    Constantin T; Rákóczi E; Ponyi A; Ambrus C; Kádár K; Vastagh I; Dajnoki A; Tóth B; Bokrétás G; Müller V; Katona M; Csikós M; Fiedler O; Széchey R; Varga E; Rudas G; Kertész A; Molnár S; Kárpáti S; Nagy V; Magyar P; Mahdi M; Németh K; Bereczki D; Garami M; Erdos M; Maródi L; Fekete G;
    Orv Hetil; 2010 Feb; 151(7):243-9. PubMed ID: 20133243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.
    Valbuena C; Leitão D; Carneiro F; Oliveira JP
    Virchows Arch; 2012 Feb; 460(2):211-21. PubMed ID: 22205110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.